The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 15, 2022

Filed:

Apr. 12, 2017
Applicant:

Abclon Inc., Seoul, KR;

Inventors:

Jong Seo Lee, Gyeonggi-do, KR;

Kyu Tae Kim, Gyeonggi-Do, KR;

Young Ha Lee, Seoul, KR;

In Sik Hwang, Incheon, KR;

Bong Kook Ko, Seoul, KR;

Assignee:

ABCLON INC., Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 16/32 (2006.01); A61K 39/00 (2006.01); G01N 33/574 (2006.01); A61K 39/395 (2006.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/32 (2013.01); A61K 39/00 (2013.01); A61K 39/395 (2013.01); A61P 35/00 (2018.01); A61P 43/00 (2018.01); G01N 33/574 (2013.01); C07K 2317/24 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01);
Abstract

The present invention replaces an amino acid residue of a specific region of a parent antibody so as to improve the stability of the antibody, thereby improving druggability. A variant antibody of the present invention, compared to a parent antibody hz1E11, has significantly improved stability while having nearly the same productivity and efficacy. Therefore, the variant antibody of the present invention exhibits, in the development of HER2-specific antibodies, excellent characteristics such as reduction in production costs, inhibition of efficacy reduction and reduction of side effects.


Find Patent Forward Citations

Loading…